Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2076

Related Citations for PubMed (Select 23519008)

1.

Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.

Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF.

Invest Radiol. 2013 May;48(5):247-55. doi: 10.1097/RLI.0b013e31828d56a1.

PMID:
23519008
2.

Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?

Regier M, Derlin T, Schwarz D, Laqmani A, Henes FO, Groth M, Buhk JH, Kooijman H, Adam G.

Eur J Radiol. 2012 Oct;81(10):2913-8. doi: 10.1016/j.ejrad.2011.11.050. Epub 2011 Dec 23.

PMID:
22197090
3.

Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).

Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS.

Eur J Radiol. 2013 Nov;82(11):2055-60. doi: 10.1016/j.ejrad.2013.05.027. Epub 2013 Jul 5.

PMID:
23830904
4.

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.

Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.

Rofo. 2013 Nov;185(11):1056-62. doi: 10.1055/s-0033-1350110. Epub 2013 Jul 16.

5.

Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.

Rakheja R, Chandarana H, DeMello L, Jackson K, Geppert C, Faul D, Glielmi C, Friedman KP.

AJR Am J Roentgenol. 2013 Nov;201(5):1115-9. doi: 10.2214/AJR.13.11304.

PMID:
24147485
6.

Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.

Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.

J Nucl Med. 2014 Feb;55(2):191-7. doi: 10.2967/jnumed.113.123646. Epub 2013 Dec 5.

7.

Integrated whole-body PET/MR hybrid imaging: clinical experience.

Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M.

Invest Radiol. 2013 May;48(5):280-9. doi: 10.1097/RLI.0b013e3182845a08.

PMID:
23442775
8.

Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.

Schmidt S, Dunet V, Koehli M, Montemurro M, Meuli R, Prior JO.

Acta Radiol. 2013 Oct;54(8):837-42. doi: 10.1177/0284185113485732. Epub 2013 May 9.

PMID:
23761549
9.

Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer.

Ho KC, Lin G, Wang JJ, Lai CH, Chang CJ, Yen TC.

Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):200-8. doi: 10.1007/s00259-008-0936-5. Epub 2008 Sep 9.

PMID:
18779960
10.

Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.

Cafagna D, Rubini G, Iuele F, Maggialetti N, Notaristefano A, Pinto D, Niccoli-Asabella A, Palmiotti G, Lasciarrea M, Maggialetti A.

Radiol Med. 2012 Mar;117(2):293-311. doi: 10.1007/s11547-011-0708-3. Epub 2011 Jul 9.

PMID:
21744252
11.

Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system?

Buchbender C, Hartung-Knemeyer V, Heusch P, Heusner TA, Beiderwellen K, Wittsack HJ, Kühl H, Forsting M, Bockisch A, Antoch G, Lanzman RS.

Eur J Radiol. 2013 Feb;82(2):380-4. doi: 10.1016/j.ejrad.2012.11.018. Epub 2012 Dec 10.

PMID:
23238361
12.

Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.

Mori T, Nomori H, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y.

J Thorac Oncol. 2008 Apr;3(4):358-64. doi: 10.1097/JTO.0b013e318168d9ed.

PMID:
18379353
13.

No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study.

Wu X, Korkola P, Pertovaara H, Eskola H, Järvenpää R, Kellokumpu-Lehtinen PL.

Eur J Radiol. 2011 Aug;79(2):e117-21. doi: 10.1016/j.ejrad.2011.04.062. Epub 2011 May 18.

PMID:
21596501
14.

PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.

Rauscher I, Eiber M, Fürst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ.

J Nucl Med. 2014 May;55(5):724-9. doi: 10.2967/jnumed.113.129247. Epub 2014 Mar 20.

PMID:
24652827
15.

Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.

Wong CS, Gong N, Chu YC, Anthony MP, Chan Q, Lee HF, Chu KM, Khong PL.

Eur J Radiol. 2012 Sep;81(9):2122-6. doi: 10.1016/j.ejrad.2011.09.003. Epub 2011 Sep 28.

PMID:
21955604
16.

Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.

Schwenzer NF, Schraml C, Müller M, Brendle C, Sauter A, Spengler W, Pfannenberg AC, Claussen CD, Schmidt H.

Radiology. 2012 Aug;264(2):551-8. doi: 10.1148/radiol.12111942. Epub 2012 May 31.

PMID:
22653189
17.

2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.

Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagi H, Ogura Y, Aga F, Adachi I.

Ann Nucl Med. 2007 Jun;21(4):209-15. Epub 2007 Jun 25.

PMID:
17581719
18.

Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.

Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, Korkola P, Soimakallio S, Eskola H, Dastidar P.

NMR Biomed. 2011 Dec;24(10):1181-90. doi: 10.1002/nbm.1689. Epub 2011 Mar 8.

PMID:
21387451
19.

Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.

Heusch P, Buchbender C, Köhler J, Nensa F, Gauler T, Gomez B, Reis H, Stamatis G, Kühl H, Hartung V, Heusner TA.

J Nucl Med. 2014 Mar;55(3):373-8. doi: 10.2967/jnumed.113.129825. Epub 2014 Feb 6.

20.

Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?

Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, Zhou DQ, Dai YM, Lin Y, Lu M, Huang XQ, Xu CX, Chen L.

Magn Reson Imaging. 2010 Jun;28(5):613-20. doi: 10.1016/j.mri.2010.02.009. Epub 2010 Apr 24.

PMID:
20418042
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk